Paper37568601
Amorphous Calcium Carbonate Shows Anti-Cancer Properties That are Attributed to Its Buffering Capacity.
Natan Y and 6 others. Cancers (Basel), 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Amorphous Calcium Carbonate Shows Anti-Cancer Properties That are Attributed to Its Buffering Capacity. Papers, record 37568601. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37568601
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Amorphous Calcium Carbonate Shows Anti-Cancer Properties That are Attributed to Its Buffering Capacity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 001 | Amorphical Ltd. | PubMed |
Source PubMed
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19276390 | Bicarbonate increases tumor pH and inhibits spontaneous metastases. | Cancer Res | 2009 | https://conductscience.org/library/papers/19276390 | PubMed |
| 2 | 30967542 | Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. | Nat Commun | 2019 | https://conductscience.org/library/papers/30967542 | PubMed |
| 3 | 26771021 | The Molecular Signatures Database (MSigDB) hallmark gene set collection. | Cell Syst | 2015 | https://conductscience.org/library/papers/26771021 | PubMed |
| 4 | 10362108 | Enhancement of chemotherapy by manipulation of tumour pH. | Br J Cancer | 1999 | https://conductscience.org/library/papers/10362108 | PubMed |
| 5 | 33898323 | Targeting c-Jun in A549 Cancer Cells Exhibits Antiangiogenic Activity In Vitro and In Vivo Through Exosome/miRNA-494-3p/PTEN Signal Pathway. | Front Oncol | 2021 | https://conductscience.org/library/papers/33898323 | PubMed |
| 6 | 27294003 | Cisplatin suppresses the growth and proliferation of breast and cervical cancer cell lines by inhibiting integrin β5-mediated glycolysis. | Am J Cancer Res | 2016 | https://conductscience.org/library/papers/27294003 | PubMed |
| 7 | 31069574 | Acidosis and proteolysis in the tumor microenvironment. | Cancer Metastasis Rev | 2019 | https://conductscience.org/library/papers/31069574 | PubMed |
| 8 | 17465550 | Understanding the effect of carbonate ion on cisplatin binding to DNA. | J Am Chem Soc | 2007 | https://conductscience.org/library/papers/17465550 | PubMed |
| 9 | 31730395 | The Acidic Tumor Microenvironment as a Driver of Cancer. | Annu Rev Physiol | 2020 | https://conductscience.org/library/papers/31730395 | PubMed |
| 10 | 24340132 | Cathepsins mediate tumor metastasis. | World J Biol Chem | 2013 | https://conductscience.org/library/papers/24340132 | PubMed |
| 11 | 23122428 | Lung cancer signature biomarkers: tissue specific semantic similarity based clustering of digital differential display (DDD) data. | BMC Res Notes | 2012 | https://conductscience.org/library/papers/23122428 | PubMed |
| 12 | 28827680 | Chemotherapy with cisplatin: insights into intracellular pH and metabolic landscape of cancer cells in vitro and in vivo. | Sci Rep | 2017 | https://conductscience.org/library/papers/28827680 | PubMed |
| 13 | 28811252 | Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma. | Hum Pathol | 2018 | https://conductscience.org/library/papers/28811252 | PubMed |
| 14 | 26745389 | Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth in vivo. | Nanoscale | 2016 | https://conductscience.org/library/papers/26745389 | PubMed |
| 15 | 25988385 | Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment. | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/25988385 | PubMed |
| 16 | 18775299 | Cancer cell metabolism: Warburg and beyond. | Cell | 2008 | https://conductscience.org/library/papers/18775299 | PubMed |
| 17 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 18 | 36284313 | B3GALT4 remodels the tumor microenvironment through GD2-mediated lipid raft formation and the c-met/AKT/mTOR/IRF-1 axis in neuroblastoma. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/36284313 | PubMed |
| 19 | 11752295 | Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. | Nucleic Acids Res | 2002 | https://conductscience.org/library/papers/11752295 | PubMed |
| 20 | 21981633 | Drug resistance and cellular adaptation to tumor acidic pH microenvironment. | Mol Pharm | 2011 | https://conductscience.org/library/papers/21981633 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41737046 | Glioma Cell Membrane-Coated CaCO3 Nanoparticles for Localized Postoperative Chemo-Calcium Overload Therapy to Prevent Glioma Recurrence. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41737046 | PubMed |
| 39062071 | Anti-Cancer Activities of Nano Amorphous Calcium Phosphates toward Premalignant and Oral Cancer Cells. | Biomedicines | 2024 | https://conductscience.org/library/papers/39062071 | PubMed |
| 38983767 | Amorphous calcium carbonate as a novel potential treatment for osteoarthritis in dogs: a pilot clinical study. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/38983767 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CTSB | 1508 | PubTator's text mining | https://conductscience.org/library/genes/1508 | NCBI Gene |
| JUN | 3725 | PubTator's text mining | https://conductscience.org/library/genes/3725 | NCBI Gene |
| SNAI2 | 6591 | PubTator's text mining | https://conductscience.org/library/genes/6591 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37568601
GET https://conductscience.org/api/papers/v1/37568601/references?page=2